Oncology is changing rapidly and new successful therapies are raising hopes. As oncology is changing, the contribution of mistletoe therapy must evolve and redefine its place. For this reason, the role of mistletoe in tumour therapy is scientifically re-examined at regular intervals in the so-called Mistletoe Symposia, which have been held since 1995 (www.mistelsymposiume.de), and subsequently presented in a book.
The new book in this series contains 49 contributions from the fields of biology, pharmacy and pharmacology, preclinical and clinical studies with findings from therapeutic experience and clinical trials, as well as reviews presented at the 7th Mistletoe Symposium in November 2019. The clinical part of the symposium is focussed on bronchial and breast carcinoma: What is the potential of conventional tumour therapy, what contribution does mistletoe make, e.g. in different dosages and forms of application, and how does mistletoe therapy also help patients in the psychological dimension? A further focus is on checkpoint inhibitors and modern immunological therapies with which mistletoe is used. The abstracts in German and English preceding each article provide a good overview of the respective topic. All contributions are vividly supplemented with graphics, diagrams and photos. Detailed reference lists and correspondence addresses facilitate further, more in-depth work.
The book is a contribution to integrative oncology, the medicine of the future. Like its 6 predecessor volumes, it is an important reference work for all those who wish to inform themselves about the state of theoretical and practical knowledge and clinical evidence of mistletoe therapy.